These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 22735753)

  • 1. Clinical presentation, diagnosis, and prognosis of myelodysplastic syndromes.
    Foran JM; Shammo JM
    Am J Med; 2012 Jul; 125(7 Suppl):S6-13. PubMed ID: 22735753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a scoring system to establish the probability of myelodysplastic syndrome in patients with unexplained cytopenias or macrocytosis.
    Rauw J; Wells RA; Chesney A; Reis M; Zhang L; Buckstein R
    Leuk Res; 2011 Oct; 35(10):1335-8. PubMed ID: 21704372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical analysis of bicytopenia and pancytopenia during pregnancy].
    Zhang C; Liang MY; Wang SM
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):488-91. PubMed ID: 19957545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes.
    Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
    Int J Hematol; 1993 Aug; 58(1-2):53-61. PubMed ID: 8219112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts].
    Yu MH; Xu ZF; Li L; Nie L; Liu L; Zhang Y; Qin TJ; Hao YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):3-7. PubMed ID: 19563026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myeloproliferative syndromes].
    Ganser A
    Ther Umsch; 1996 Feb; 53(2):97-102. PubMed ID: 8629270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A feature of hematological findings in myelodysplastic syndromes].
    Bando S; Niiya T; Murase M; Makino H
    Rinsho Byori; 1998 Aug; 46(8):790-5. PubMed ID: 9760831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelodysplastic syndromes: the pediatric point of view.
    Locatelli F; Zecca M; Pession A; Maserati E; De Stefano P; Severi F
    Haematologica; 1995; 80(3):268-79. PubMed ID: 7672722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference.
    Valent P; Horny HP; Bennett JM; Fonatsch C; Germing U; Greenberg P; Haferlach T; Haase D; Kolb HJ; Krieger O; Loken M; van de Loosdrecht A; Ogata K; Orfao A; Pfeilstöcker M; Rüter B; Sperr WR; Stauder R; Wells DA
    Leuk Res; 2007 Jun; 31(6):727-36. PubMed ID: 17257673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myelodysplastic syndromes].
    Solary E; Fontenay M
    Rev Prat; 2010 Dec; 60(10):1408-9, 1412. PubMed ID: 21425540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelodysplastic syndromes: a practical approach to diagnosis and treatment.
    Barzi A; Sekeres MA
    Cleve Clin J Med; 2010 Jan; 77(1):37-44. PubMed ID: 20048028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myelodysplastic syndromes. A clinico-biological analysis of 27 cases].
    Mereuţă A; Turtureanu-Hanganu E
    Rev Med Chir Soc Med Nat Iasi; 1990; 94(1):67-73. PubMed ID: 2075337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Myelodysplastic syndromes].
    Garandeau C; Pautas E; Andreux M; Andreux J; Gaussem P; Siguret V
    Ann Biol Clin (Paris); 2000; 58(4):405-16. PubMed ID: 10932040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conventional cytogenetics and fluorescence in situ hybridization in persistent cytopenias and myelodysplastic syndromes in childhood.
    Touliatou V; Kolialexi A; Tsangaris GT; Moschovi M; Polychronopoulou S; Mavrou A
    Anticancer Res; 2004; 24(6):3945-9. PubMed ID: 15736436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the prevalence of myelodysplastic syndromes in patients with unexplained cytopenias: a retrospective study of 322 bone marrows.
    Buckstein R; Jang K; Friedlich J; Zhang L; Reis M; Chesney A; Wells RA
    Leuk Res; 2009 Oct; 33(10):1313-8. PubMed ID: 19282029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary myelodysplastic syndrome in children].
    Kuzmanović M; Bunjevacki G; Rasović N; Vujić D; Mićić D; Guć-Sćekić M; Jovanović V
    Srp Arh Celok Lek; 2001; 129 Suppl 1():10-6. PubMed ID: 15637984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias.
    Cremers EMP; Westers TM; Alhan C; Cali C; Wondergem MJ; Poddighe PJ; Ossenkoppele GJ; van de Loosdrecht AA
    Eur J Cancer; 2016 Feb; 54():49-56. PubMed ID: 26720403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in multi-lineage and erythroid progenitors distinguishes myelodysplastic syndromes from non-malignant cytopenias.
    Vercauteren SM; Bashashati A; Wu D; Brinkman RR; Eaves C; Eaves A; Karsan A
    Leuk Res; 2009 Dec; 33(12):1636-42. PubMed ID: 19414193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia.
    Cermák J; Belicková M; Krejcová H; Michalová K; Zilovcová S; Zemanová Z; Brezinová J; Sieglová Z
    Leuk Res; 2005 Apr; 29(4):371-9. PubMed ID: 15725470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.